These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9597553)

  • 1. Fenoldopam: a new dopamine agonist for the treatment of hypertensive urgencies and emergencies.
    Post JB; Frishman WH
    J Clin Pharmacol; 1998 Jan; 38(1):2-13. PubMed ID: 9597553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenoldopam: a review of its pharmacodynamic and pharmacokinetic properties and intravenous clinical potential in the management of hypertensive urgencies and emergencies.
    Brogden RN; Markham A
    Drugs; 1997 Oct; 54(4):634-50. PubMed ID: 9339965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension.
    Murphy MB; Murray C; Shorten GD
    N Engl J Med; 2001 Nov; 345(21):1548-57. PubMed ID: 11794223
    [No Abstract]   [Full Text] [Related]  

  • 4. Fenoldopam: a new parenteral antihypertensive: consensus roundtable on the management of perioperative hypertension and hypertensive crises.
    Oparil S; Aronson S; Deeb GM; Epstein M; Levy JH; Luther RR; Prielipp R; Taylor A
    Am J Hypertens; 1999 Jul; 12(7):653-64. PubMed ID: 10411362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial experience with fenoldopam in children.
    Strauser LM; Pruitt RD; Tobias JD
    Am J Ther; 1999 Sep; 6(5):283-8. PubMed ID: 11329109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fenoldopam: potential clinical applications in heart surgery].
    Shorten GD
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):487-91. PubMed ID: 11792308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenoldopam--a new drug for parenteral treatment of severe hypertension.
    Med Lett Drugs Ther; 1998 May; 40(1027):57-8. PubMed ID: 9618665
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of the DA1 receptor agonist fenoldopam in the management of critically ill, transplant, and hypertensive patients.
    Mathur VS
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S35-40. PubMed ID: 12556736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenoldopam for hypertensive emergencies.
    Hoekstra JW
    Acad Emerg Med; 1995 Nov; 2(11):947-8. PubMed ID: 8536118
    [No Abstract]   [Full Text] [Related]  

  • 10. Fenoldopam versus nitroprusside for the treatment of hypertensive emergency.
    Devlin JW; Seta ML; Kanji S; Somerville AL
    Ann Pharmacother; 2004 May; 38(5):755-9. PubMed ID: 15039472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic and sympathetic effects of fenoldopam and sodium nitroprusside.
    Yakazu Y; Iwasawa K; Narita H; Kindscher JD; Benson KT; Goto H
    Acta Anaesthesiol Scand; 2001 Oct; 45(9):1176-80. PubMed ID: 11683671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension.
    White WB; Halley SE
    Arch Intern Med; 1989 Apr; 149(4):870-4. PubMed ID: 2565105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DA1-receptor stimulation by fenoldopam in the treatment of postcardiac surgical hypertension.
    Gombotz H; Plaza J; Mahla E; Berger J; Metzler H
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):834-40. PubMed ID: 9698961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects.
    Mathur VS; Swan SK; Lambrecht LJ; Anjum S; Fellmann J; McGuire D; Epstein M; Luther RR
    Crit Care Med; 1999 Sep; 27(9):1832-7. PubMed ID: 10507606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained hemodynamic effects of the selective dopamine-1 agonist, fenoldopam, during 48-hour infusions in hypertensive patients: a dose-tolerability study.
    Taylor AA; Mangoo-Karim R; Ballard KD; Luther RR; Pool JL
    J Clin Pharmacol; 1999 May; 39(5):471-9. PubMed ID: 10234594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing contrast-induced nephropathy with fenoldopam.
    Hunter DW; Chamsuddin A; Bjarnason H; Kowalik K
    Tech Vasc Interv Radiol; 2001 Mar; 4(1):53-6. PubMed ID: 11981789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with intravenous fenoldopam.
    Holcslaw TL; Beck TR
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fenoldopam and kidney function in a case of abdominal aortic pseudoaneurysm with supra-renal clamping in an emergency protocol].
    Caporelli S; Loggi S; Zompanti V; Romano R; Carbonari L; Alò F; Antognini M; Pelaia P
    Recenti Prog Med; 2003 Nov; 94(11):501-5. PubMed ID: 14679918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic profile of intravenous fenoldopam in patients with hypertensive crisis.
    Bodmann KF; Tröster S; Clemens R; Schuster HP
    Clin Investig; 1993 Dec; 72(1):60-4. PubMed ID: 7907900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
    Shusterman NH; Elliott WJ; White WB
    Am J Med; 1993 Aug; 95(2):161-8. PubMed ID: 8102835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.